Search Results - "Astorga, Beatriz Gonzalez"

Dynamic nature of BRAF or KRAS p.G12C mutations in second-line therapy for advanced colorectal cancer patients: do early and late effects exist? by Contreras-Toledo, Débora, Jiménez-Fonseca, Paula, López, Carlos López, Montes, Ana Fernández, López Muñoz, Ana María, Vázquez Rivera, Francisca, Alonso, Vicente, Alcaide, Julia, Salvà, Francesc, Covela Rúa, Marta, Guillot, Mónica, Martín Carnicero, Alfonso, Jimeno Mate, Raquel, Cameselle García, Soledad, Asensio Martínez, Elena, González Astorga, Beatriz, Fernandez-Diaz, Amaya B., González Villaroel, Paula, Virgili Manrique, Anna C., Melián Sosa, Marcos, Alonso, Beatriz, Cousillas Castiñeiras, Antia, Castañón López, Carmen, Aparicio, Jorge, Carmona-Bayonas, Alberto

“…Introduction The mitogen-activated protein kinase (MAPK) signalling network aberrations in metastatic colorectal cancer (mCRC) generate intrinsic dynamic…”
Get full text

Novel Genetic Variants Explaining Severe Adverse Drug Events after Clinical Implementation of DPYD Genotype-Guided Therapy with Fluoropyrimidines: An Observational Study by Díaz-Villamarín, Xando, Martínez-Pérez, María, Nieto-Sánchez, María Teresa, Ruiz-Tueros, Gabriela, Fernández-Varón, Emilio, Torres-García, Alicia, González Astorga, Beatriz, Blancas, Isabel, Iáñez, Antonio J, Cabeza-Barrera, José, Morón, Rocío

“…Fluoropyrimidines (FPs) are commonly prescribed in many cancer streams. The EMA and FDA-approved drug labels for FPs recommend genotyping the *2A (rs3918290),…”
Get full text

A phase 2 study for evaluating doxycycline 50 mg once daily and 100 mg once daily as preemptive treatment for skin toxicity in patients with metastatic colorectal cancer treated with an anti-EGFR and chemotherapy by Ramírez-Daffós, Patricia, Jiménez-Orozco, Encarnación, Bolaños, Matilde, González Astorga, Beatriz, Rubiales, Sandra, Ceballos-Barbancho, Eduardo, Rodríguez García, José Manuel, Reina, Juan-José

“…Purpose To assess the efficacy, safety, and quality-of-life outcomes of doxycycline 50 or 100 mg once daily in the prevention of skin toxicity in patients…”
Get full text

Real-world study on microsatellite instability and mismatch repair deficiency testing patterns among patients with metastatic colorectal cancer in Spain by Garcia-Carbonero, Rocio, González Astorga, Beatriz, Vidal Tocino, Rosario, Contreras Toledo, Débora, Pericay, Carles, Fernández Montes, Ana, Falcó, Esther, González Cordero, Marta, Reina Zoilo, Juan José, Alonso, Vicente, Rodríguez Salas, Nuria, Gil-Raga, Mireia, Santos, Cristina, Páez, David, Anton-Pascual, Beatriz, Aguilar, Fernando, Morales, Pilar

“…Purpose Clinical practice guidelines recommend that all patients with metastatic colorectal cancer (mCRC) should be tested for mismatch repair deficiency…”
Get full text

Axitinib treatment in advanced RAI-resistant differentiated thyroid cancer (DTC) and refractory medullary thyroid cancer (MTC) by Capdevila, Jaume, Trigo, José Manuel, Aller, Javier, Manzano, José Luís, Adrián, Silvia García, Llopis, Carles Zafón, Reig, Òscar, Bohn, Uriel, Cajal, Teresa Ramón y, Duran-Poveda, Manuel, Astorga, Beatriz González, López-Alfonso, Ana, Martínez, Javier Medina, Porras, Ignacio, Reina, Juan Jose, Palacios, Nuria, Grande, Enrique, Cillán, Elena, Matos, Ignacio, Grau, Juan Jose

“…Background Axitinib, an antiangiogenic multikinase inhibitor (MKI), was evaluated in the compassionate use programme (CUP) in Spain (October 2012–November…”
Get full text

Early Clinical Experience with Trifluridine/Tipiracil for Refractory Metastatic Colorectal Cancer: The ROS Study by García-Alfonso, Pilar, Muñoz, Andrés, Jiménez-Castro, Jerónimo, Jiménez-Fonseca, Paula, Pericay, Carles, Longo-Muñoz, Federico, Reyna-Fortes, Carmen, Argilés-Martínez, Guillem, González-Astorga, Beatriz, Gómez-Reina, María José, Ruiz-Casado, Ana, Rodríguez-Salas, Nuria, López-López, Rafael, Carmona-Bayonas, Alberto, Conde-Herrero, Verónica, Aranda, Enrique

“…Trifluridine/tipiracil is currently approved for metastatic colorectal cancer (mCRC) refractory to available therapies. However, there is no consensus on…”
Get full text

Biochemotherapy in the treatment of metastatic melanoma in selected patients by González Astorga, Beatriz, Jiménez Rubiano, Berta, Delgado Pérez, Juan Ramón, Valdivia Bautista, Javier, Sánchez Toro, Carmen, González Flores, Encarnación, Luque Caro, Raquel, Castellón Rubio, Victoria

“…Introduction Bioimmunochemotherapy (BCT) is a combination of biological agents and cytostatics that has shown an increase in response rate (RR) in metastatic…”
Get full text

Two Randomized Controlled Trials of Romiplostim for Chemotherapy-Induced Thrombocytopenia in Patients with Solid Tumors by Al-Samkari, Hanny, Geredeli, Caglayan, Arslan, Cagatay, Korantzis, Ippokratis, Dogu, Gamze Gokoz, Nechaeva, Marina, Fernandez, Mercedes Salgado, Astorga, Beatriz Gonzalez, Yordanov, Valeriy, Ciuleanu, Tudor-eliade, Bowers, Charles, Armas, Armando, Scotte, Florian, Camargo, Johnny, Muñoz, César, Bunn, Paul, Kuter, David J., Soff, Gerald A.

Get full text

Early clinical experience with trifluridine/tipiracil for refractory metastatic colorectal cancer: The ROS study by Garcia-Alfonso, Pilar, Muñoz Martín, Andres J., Jimenez-Castro, Jeronimo, Jiménez-Fonseca, Paula, Pericay, Carles, Longo, Federico, Reyna, Carmen, Argiles, Guillem, Gonzalez Astorga, Beatriz, Gomez-Reina, Maria Jose, Ruíz Casado, Ana, Rodriguez-Salas, Nuria, Lopez-Lopez, Rafael, Carmona Bayonas, Alberto, Conde-Herrero, Veronica, Aranda, Enrique

“…Abstract only e15556 Background: Trifluridine/tipiracil is currently approved for metastatic colorectal cancer (mCRC) refractory to available therapies…”
Get full text

Influence of CYP2D6 polymorphism in the outcome of breast cancer patients undergoing tamoxifen adjuvant treatment by Blancas, Isabel, Rodriguez Gonzalez, Carols Jose, Muñoz-Serrano, Antonio Jesús, Delgado, María Teresa, Legerén, Marta, Gonzalez Astorga, Beatriz, Jurado, Jose Miguel, Yélamos, Marisol, Sequero, Silvia, Rodríguez-Serrano, Fernando

“…Abstract only…”
Get full text

Recommendations for the management of yttrium-90 radioembolization in the treatment of patients with colorectal cancer liver metastases: a multidisciplinary review by González-Flores, Encarna, Zambudio, Natalia, Pardo-Moreno, Pedro, Gonzalez-Astorga, Beatriz, de la Rúa, Jorge Roldán, Triviño-Ibáñez, Eva M., Navarro, Pablo, Espinoza-Cámac, Nataly, Casado, Miguel Ángel, Rodríguez-Fernández, Antonio

“…Purpose Strategies for the treatment of liver metastases from colon cancer (lmCRC) are constantly evolving. Radioembolization with yttrium 90 (Y-90 TARE) has…”
Get full text

Preliminary clinical and pathologic characteristics of patients treated in second-line (2L) with 25 cycles (Cy) or more of FOLFIRI + Aflibercept (FA) by Pericay, Carles, Martinez, Nieves Purificacion, Corral, Monica, Macias, Ismael, Donnay, Olga, Juez, Ignacio, García-Paredes, Beatriz, Mendez, Jose Carlos, Cacho, Diego, Gonzalez Astorga, Beatriz, Ruiz, Ana, Delgado, Mayte, Rodriguez, Nuria, Calderero, Veronica, Mata, Elena, Barrera Ramirez, Juan Antonio

“…Abstract only…”
Get full text

MDR1 gene expression in peripheral blood as a marker of treatment response in lung cancer by Luque, Raquel, Gonzalez Flores, Encarnacion, Delgado, Juan Ramon, Melguizo, Consolación, Prados, Jose Carlos, Gonzalez Astorga, Beatriz, Ortiz, Raul, Sánchez Toro, Carmen, Valdivia, Javier, Aránega, Antonia

“…Abstract only 96 Background: Non-small cell lung cancer (NSCLC) is sometimes chemoresistant and does not respond to treatment; several factors are involved in…”
Get full text

Regorafenib as a single agent for first-line treatment of frail and/or unfit for polychemotherapy patients with metastatic colorectal cancer (mCRC): A study of the Spanish Cooperative Group for digestive tumor therapy (TTD) by Grande, Enrique, Guillen-Ponce, Carmen, Vieitez de Prado, Jose Maria, Reboredo, Margarita, Duran, Gema, Massuti Sureda, Bartolomeu, Layos, Laura, Salud, Antonia, Falco, Esther, Alonso, Vicente, Garcia Alfonso, Pilar, Ortiz, Maria Jose, Sastre, Javier, Rivera, Fernando, Gallego, Javier, Robles, Luis, Gonzalez Astorga, Beatriz, Dotor, Emma, Carrato, Alfredo, Aranda, Enrique

“…Abstract only…”
Get full text

Axitinib treatment in advanced RAI-resistant differentiated thyroid cancer (DTC) and refractory medullary thyroid cancer (MTC) by Capdevila, Jaume, Trigo Perez, Jose Manuel, Aller, Javier, Manzano, Jose Luis, Garcia Adrian, Silvia, Zafon, Carles, Reig, Òscar, Bohn, Uriel, Cillan, Elena, Duran, Manuel, Gonzalez Astorga, Beatriz, Lopez, Ana, Javier, Medina, Porras, Ignacio, Reina, Juan J, Palacios, Nuria, Grande, Enrique, Grau, Juan J.

“…Abstract only…”
Get full text

P-0228 The CEA Biochemical Response of Metastatic Colorectal Cancer Treated with Bevacizumab by Gonzalez-Astorga, Beatriz, González-Flores, Encarnación, Garcia, Javier Garcia, Gonzalez-Vicente, Aranzazu, Soberino, Jesus, Gonzalez, Cynthia, Ruiz, Julia, Conde, Verónica, Delgado, Juan Ramón

Get full text

PD-0007 18F-Fdg Positron Emission Tomography (FDG-PET) and Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer by González-Flores, Encarnación, Ruiz, Julia, Gonzalez-Astorga, Beatriz, Conde, Verónica, Garcia, Javier Garcia, Gonzalez-Vicente, Aranzazu, Soberino, Jesus, Gonzalez, Cynthia, Raquel, Luque-Caro, Sanchez-Toro, Carmen, Martinez-Galan, Joaquina, Delgado, Juan Ramón

Get full text

P-0144 Adjuvant Therapy and Prognostic Factors for Biliary Tract Cancer Intrahepatic Cholangiocarcinoma: Single-Center Experience by Martinez-Galan, Joaquina, Garcia, Javier Garcia, K-Granero, Karim Muffa, Ortega, José Antonio, Gonzalez-Astorga, Beatriz, Conde, Verónica, Garrote, Daniel, González-Vicente, Aranzazú, Ferrón, Jose Antonio, Delgado, Juan Ramón

Get full text

Experience with aflibercept as a second line chemotherapy in metastatic colorectal cancer: Safety and efficacy in a real-life population by González-Flores, Encarnación, González-Astorga, Beatriz, Delgado Ureña Ma, Teresa, González Cebrián, Irene, Sánchez-Toro, Carmen, García-García, Javier, Conde, Verónica

Get full text

Analysis retrospective from efficacy with TAS-102 in patients with metastatic colorectal cancer refractory: Experience at two hospitals by González-Astorga, Beatriz, González Cebrián, Irene, Delgado Ureña Ma, Teresa, Conde, Verónica, Sánchez-Toro, Carmen, García-García, Javier, González-Flores, Encarnación

Get full text